Anastrozole 0.5 mg 60 capsules by Swiss Chem

Description

Anastrozole: A Potent Non-Steroidal Aromatase Inhibitor for Research

Anastrozole, known by its synonyms Arimidex, Anastrazole, and Anastrozol, is a highly effective non-steroidal aromatase inhibitor. It works by preventing the conversion of androgens to estrogens, thereby significantly reducing circulating estrogen levels. This makes it a valuable compound for research focused on breast cancer prevention and hormone-related studies.

Chemical Properties of Anastrozole

• Chemical Formula: C17H19N5
• Molecular Mass: 293.366
• Synonyms: 120511-73-1, Arimidex, Anastrazole, Anastrozol
• Molar Mass: 293.4
• CAS Number: 120511-73-1
• PubChem: 44256128

Product Specifications

• Total Amount of Active Ingredient: 0.5 mg per capsule
• Shelf Life: 36 months
• Quality Guarantee: All our products undergo rigorous lab testing, and the results are periodically published on our website. Customers can also have their purchases tested at any HPLC-licensed facility. If the results are negative, we will refund the cost of the HPLC test, the total order amount, and the shipping fee.

Benefits of Anastrozole

• Reduces Estrogen Levels: Effectively lowers estrogen levels in the body, which is crucial for breast cancer research.
• Prevents Breast Cancer:  Proven potential as a preventive therapy for breast cancer in postmenopausal women.
• Supports Hormone Studies: Valuable for research in hormone regulation and associated disorders.

Minor Side Effects

While generally well-tolerated, some minor side effects have been observed:

• Mild nausea
• Hot flashes
• Fatigue

Dosage Recommendations

• Beginner: 0.5 mg per day
• Intermediate: 1 mg per day
• Advanced: 1.5 mg per day
• Women: 0.5 mg per day (due to gender-specific physiological responses)

Peer-Reviewed Studies

1. Bonneterre, J., et al. (2000). “Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability study.” Journal of Clinical Oncology, 18(22), 3748-3757.
2. Cuzick, J. (2008). “IBIS II: a breast cancer prevention trial in postmenopausal women using the aromatase inhibitor anastrozole.” Expert Review of Anticancer Therapy, 8(9), 1377-1385.

Bottom Line

Anastrozole is a crucial tool for research in breast cancer prevention and hormone regulation. Its ability to significantly reduce estrogen levels highlights its importance in scientific studies. Always consult with a qualified professional before incorporating new substances into research protocols.

The information presented here is not meant to replace medical advice, diagnosis, or treatment. If you have any concerns about a medical condition, it’s important to consult with your physician or a qualified healthcare professional. Never disregard or delay seeking medical advice based on what you’ve read or seen. We take no responsibility or liability for the use of our research compounds and products. Please be aware that they are exclusively intended for research purposes. We do not endorse any personal use.